Sleep problems during the menopausal transition: Prevalence, impact, and management challenges

Fiona C. Baker, Massimiliano De Zambotti, Ian M. Colrain, Bei Bei

Research output: Contribution to journalReview ArticleResearchpeer-review

Abstract

A substantial number of women experience sleep difficulties in the approach to menopause and beyond, with 26% experiencing severe symptoms that impact daytime functioning, qualifying them for a diagnosis of insomnia. Here, we review both self-report and polysomnographic evidence for sleep difficulties in the context of the menopausal transition, considering severity of sleep complaints and links between hot flashes (HFs) and depression with poor sleep. Longitudinal population-based studies show that sleep difficulties are uniquely linked with menopausal stage and changes in follicle-stimulating hormone and estradiol, over and above the effects of age. A major contributor to sleep complaints in the context of the menopausal transition is HFs, and many, although not all, HFs are linked with polysomnographic-defined awakenings, with HF-associated wake time contributing significantly to overall wakefulness after sleep onset. Some sleep complaints may be comorbid with depressive disorders or attributed to sleep-related breathing or movement disorders, which increase in prevalence especially after menopause, and for some women, menopause, age, and environmental/behavioral factors may interact to disrupt sleep. Considering the unique and multifactorial basis for sleep difficulties in women transitioning menopause, we describe clinical assessment approaches and management options, including combination treatments, ranging from cognitive behavioral therapy for insomnia to hormonal and nonhormonal pharmacological options. Emerging studies suggest that the impact of severe insomnia symptoms could extend beyond immediate health care usage and quality of life issues to long-term mental and physical health, if left untreated in midlife women. Appropriate treatment, therefore, has immediate benefit as well as advantages for maintaining optimal health in the postmenopausal years.

Original languageEnglish
Pages (from-to)73-95
Number of pages23
JournalNature and Science of Sleep
Volume10
DOIs
Publication statusPublished - 9 Feb 2018

Keywords

  • Estradiol
  • Hormone therapy
  • Hot flashes
  • Insomnia
  • Midlife women
  • Vasomotor symptoms

Cite this

Baker, Fiona C. ; De Zambotti, Massimiliano ; Colrain, Ian M. ; Bei, Bei. / Sleep problems during the menopausal transition : Prevalence, impact, and management challenges. In: Nature and Science of Sleep. 2018 ; Vol. 10. pp. 73-95.
@article{4fc76f48e8ad4d209c41dec12d0ae10f,
title = "Sleep problems during the menopausal transition: Prevalence, impact, and management challenges",
abstract = "A substantial number of women experience sleep difficulties in the approach to menopause and beyond, with 26{\%} experiencing severe symptoms that impact daytime functioning, qualifying them for a diagnosis of insomnia. Here, we review both self-report and polysomnographic evidence for sleep difficulties in the context of the menopausal transition, considering severity of sleep complaints and links between hot flashes (HFs) and depression with poor sleep. Longitudinal population-based studies show that sleep difficulties are uniquely linked with menopausal stage and changes in follicle-stimulating hormone and estradiol, over and above the effects of age. A major contributor to sleep complaints in the context of the menopausal transition is HFs, and many, although not all, HFs are linked with polysomnographic-defined awakenings, with HF-associated wake time contributing significantly to overall wakefulness after sleep onset. Some sleep complaints may be comorbid with depressive disorders or attributed to sleep-related breathing or movement disorders, which increase in prevalence especially after menopause, and for some women, menopause, age, and environmental/behavioral factors may interact to disrupt sleep. Considering the unique and multifactorial basis for sleep difficulties in women transitioning menopause, we describe clinical assessment approaches and management options, including combination treatments, ranging from cognitive behavioral therapy for insomnia to hormonal and nonhormonal pharmacological options. Emerging studies suggest that the impact of severe insomnia symptoms could extend beyond immediate health care usage and quality of life issues to long-term mental and physical health, if left untreated in midlife women. Appropriate treatment, therefore, has immediate benefit as well as advantages for maintaining optimal health in the postmenopausal years.",
keywords = "Estradiol, Hormone therapy, Hot flashes, Insomnia, Midlife women, Vasomotor symptoms",
author = "Baker, {Fiona C.} and {De Zambotti}, Massimiliano and Colrain, {Ian M.} and Bei Bei",
year = "2018",
month = "2",
day = "9",
doi = "10.2147/NSS.S125807",
language = "English",
volume = "10",
pages = "73--95",
journal = "Nature and Science of Sleep",
issn = "1179-1608",
publisher = "Nature Publishing Group",

}

Sleep problems during the menopausal transition : Prevalence, impact, and management challenges. / Baker, Fiona C.; De Zambotti, Massimiliano; Colrain, Ian M.; Bei, Bei.

In: Nature and Science of Sleep, Vol. 10, 09.02.2018, p. 73-95.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - Sleep problems during the menopausal transition

T2 - Prevalence, impact, and management challenges

AU - Baker, Fiona C.

AU - De Zambotti, Massimiliano

AU - Colrain, Ian M.

AU - Bei, Bei

PY - 2018/2/9

Y1 - 2018/2/9

N2 - A substantial number of women experience sleep difficulties in the approach to menopause and beyond, with 26% experiencing severe symptoms that impact daytime functioning, qualifying them for a diagnosis of insomnia. Here, we review both self-report and polysomnographic evidence for sleep difficulties in the context of the menopausal transition, considering severity of sleep complaints and links between hot flashes (HFs) and depression with poor sleep. Longitudinal population-based studies show that sleep difficulties are uniquely linked with menopausal stage and changes in follicle-stimulating hormone and estradiol, over and above the effects of age. A major contributor to sleep complaints in the context of the menopausal transition is HFs, and many, although not all, HFs are linked with polysomnographic-defined awakenings, with HF-associated wake time contributing significantly to overall wakefulness after sleep onset. Some sleep complaints may be comorbid with depressive disorders or attributed to sleep-related breathing or movement disorders, which increase in prevalence especially after menopause, and for some women, menopause, age, and environmental/behavioral factors may interact to disrupt sleep. Considering the unique and multifactorial basis for sleep difficulties in women transitioning menopause, we describe clinical assessment approaches and management options, including combination treatments, ranging from cognitive behavioral therapy for insomnia to hormonal and nonhormonal pharmacological options. Emerging studies suggest that the impact of severe insomnia symptoms could extend beyond immediate health care usage and quality of life issues to long-term mental and physical health, if left untreated in midlife women. Appropriate treatment, therefore, has immediate benefit as well as advantages for maintaining optimal health in the postmenopausal years.

AB - A substantial number of women experience sleep difficulties in the approach to menopause and beyond, with 26% experiencing severe symptoms that impact daytime functioning, qualifying them for a diagnosis of insomnia. Here, we review both self-report and polysomnographic evidence for sleep difficulties in the context of the menopausal transition, considering severity of sleep complaints and links between hot flashes (HFs) and depression with poor sleep. Longitudinal population-based studies show that sleep difficulties are uniquely linked with menopausal stage and changes in follicle-stimulating hormone and estradiol, over and above the effects of age. A major contributor to sleep complaints in the context of the menopausal transition is HFs, and many, although not all, HFs are linked with polysomnographic-defined awakenings, with HF-associated wake time contributing significantly to overall wakefulness after sleep onset. Some sleep complaints may be comorbid with depressive disorders or attributed to sleep-related breathing or movement disorders, which increase in prevalence especially after menopause, and for some women, menopause, age, and environmental/behavioral factors may interact to disrupt sleep. Considering the unique and multifactorial basis for sleep difficulties in women transitioning menopause, we describe clinical assessment approaches and management options, including combination treatments, ranging from cognitive behavioral therapy for insomnia to hormonal and nonhormonal pharmacological options. Emerging studies suggest that the impact of severe insomnia symptoms could extend beyond immediate health care usage and quality of life issues to long-term mental and physical health, if left untreated in midlife women. Appropriate treatment, therefore, has immediate benefit as well as advantages for maintaining optimal health in the postmenopausal years.

KW - Estradiol

KW - Hormone therapy

KW - Hot flashes

KW - Insomnia

KW - Midlife women

KW - Vasomotor symptoms

UR - http://www.scopus.com/inward/record.url?scp=85042935735&partnerID=8YFLogxK

U2 - 10.2147/NSS.S125807

DO - 10.2147/NSS.S125807

M3 - Review Article

VL - 10

SP - 73

EP - 95

JO - Nature and Science of Sleep

JF - Nature and Science of Sleep

SN - 1179-1608

ER -